Showing 1 - 4 results of 4 for search 'Hironao Okubo', query time: 0.02s Refine Results
  1. 1
    Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma

    Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma by Hironao Okubo, Hitoshi Ando, Yusuke Takasaki, Eisuke Nakadera, Yuka Fukuo, Shuichiro Shiina, Kenichi Ikejima

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma

    Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma by Hironao Okubo, Hitoshi Ando, Kei Ishizuka, Jun-ichi Morishige, Kenichi Ikejima, Shuichiro Shiina, Akihito Nagahara

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites

    Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites by Eri Sagawa, Hironao Okubo, Hitoshi Ando, Yushi Sorin, Ryo Kanazawa, Eisuke Nakadera, Hiroo Fukada, Shigehiro Kokubu, Akihisa Miyazaki

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    L-carnitine prevents lenvatinib-induced muscle toxicity without impairment of the anti-angiogenic efficacy

    L-carnitine prevents lenvatinib-induced muscle toxicity without impairment of the anti-angiogenic efficacy by Zheng Jing, Tomohiro Iba, Tomohiro Iba, Hisamichi Naito, Pingping Xu, Jun-ichi Morishige, Naoto Nagata, Hironao Okubo, Hitoshi Ando

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: